LY3884961 Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Scottsdale, Arizona1 trial

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Mayo Clinic, 13400 E. Shea Boulevard

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.